Pharmacology of Endothelial Cell Tpa/Upa Synthesis

Bjornsson, Thorir D.

Abstract

Funding Agency

• Agency: National Institute of Health (NIH)
• Institute: National Heart, Lung, and Blood Institute (NHLBI)
• Type: Research Project (R01)
• Project #: 5R01HL045593-05
• Application #: 2222283
• Study Section: Pharmacology A Study Section (PHRA)
• Project Start: 1991-01-05
• Project End: 1996-12-31
• Budget Start: 1995-01-01
• Budget End: 1996-12-31
• Support Year: 5
• Fiscal Year: 1995

Institution

• Name: Thomas Jefferson University
• Department: Internal Medicine/Medicine
• Type: Schools of Medicine
• DUNS #: 061197161
• City: Philadelphia
• State: PA
• Country: United States
• Zip Code: 19107

Publications

Sobel, M I; Winkel, C A; Macy, L B et al. (1995) The regulation of plasminogen activators and plasminogen activator inhibitor type 1 in endothelial cells by sex hormones. Am J Obstet Gynecol 173:801-8

Kuo, B S; Bjornsson, T D (1993) Simultaneous determination of free tissue-type and free urokinase-type plasminogen activators in biological fluids by a solid-phase immunoassay. Anal Biochem 209:70-8

Korner, G; Bjornsson, T D; Vlodavsky, I (1993) Extracellular matrix produced by cultured corneal and aortic endothelial cells contains active tissue-type and urokinase-type plasminogen activators. J Cell Physiol 154:456-65

Shi, Y; Nardone, D; Hernandez-Martinez, A et al. (1992) Fibrinolytic activity after vessel wall injury. J Am Coll Cardiol 19:441-3